eslicarbazepine acetate

FDA Drug Profile — Eslicarbazepine Acetate

eslicarbazepine acetate is listed in the FDA National Drug Code directory with 7 NDC codes, marketed under brand name including Eslicarbazepine Acetate. Available dosage forms: tablet, powder.

Drug Details

Generic Name
eslicarbazepine acetate
Brand Names
Eslicarbazepine Acetate
Application Number
ANDA211219
Sponsor
Jubilant Cadista Pharmaceuticals Inc.
NDC Codes
7
Dosage Forms
TABLET, POWDER
Routes
ORAL
Active Ingredients
ESLICARBAZEPINE ACETATE

Indications and Usage

1 INDICATIONS AND USAGE APTIOM is indicated for the treatment of partial-onset seizures in patients 4 years of age and older. APTIOM is indicated for the treatment of partial-onset seizures in patients 4 years of age and older. ( 1 )